The health-related quality of life in patients with dry eye syndrome: a cross-sectional study in Thailand
- PMID: 39695504
- PMCID: PMC11658330
- DOI: 10.1186/s12886-024-03808-9
The health-related quality of life in patients with dry eye syndrome: a cross-sectional study in Thailand
Abstract
Background: Dry eye syndrome (DES) is common but lack of data in quality of life (QoL) of DES patients in Thailand. The primary outcome of this study was to determine QoL and health utility in patients of DES by EuroQol 5-domain (EQ-5D) of the 5-level version (5 L) instrument. The secondary outcome was comparison of the utility in the patients of DES classified by severity and causes including the autoimmune and non-autoimmune diseases.
Method: The study was a cross-sectional study at a hospital in the northern part of Thailand. The inclusions DES patients were followed by Tear Film and Ocular surface Society the Dry Eye WorkShop II definition. The EQ-5D-5 L (Thai version) descriptive system and the EQ visual analogue scale (VAS) was instrument for QoL evaluation.
Result: Total patients of DES were fifty-six. The most patients were female. The mean age was 57.7(± 13.9) years. The mean of EQ-5D-utility and EQ-VAS were 0.76 (± 0.18) and 72.56 (± 15.19), respectively. The mean of EQ-5D-utility in these patients who were classified by severity including mild, moderate and severe were 0.84 (± 0.16), 0.78 (± 0.14) and 0.71 (± 0.22), respectively. There is no statistic significant in the EQ-5D-utility and EQ-VAS among severity and the causes of these patients.
Conclusions: This study demonstrated the importance of assessing QoL in DES. The EQ-5D-utility was accorded with the severity of DES. However, no statistic significant was showed in the mean of EQ-5D-utility and EQ-VAS between the severity and between the causes including the autoimmune and non-autoimmune diseases of these patients.
Keywords: Autoimmune; Dry eye syndrome; EQ-5D-5L; Quality of life; Utility.
© 2024. The Author(s).
Conflict of interest statement
Declarations. Ethical approval: Ethical approval was achieved by the Naresuan University Institutional Review Board and Ethics Committee (IRB No. P3-0041/2565). The Ethics Committees were in accordance with the Declaration of Helsinki. Consent to participate: Informed consent was obtained from all including dry eye syndrome patients. Consent for publication: Not applicable. Competing interests: The authors declare no competing interests.
Figures
Similar articles
-
Dry eye symptoms and health-related quality of life among Chinese individuals: a national-based study.Br J Ophthalmol. 2024 Oct 22;108(11):1500-1507. doi: 10.1136/bjo-2023-324677. Br J Ophthalmol. 2024. PMID: 38471750
-
Health Utility Values Among Patients With Diabetic Retinopathy, Wet Age-Related Macular Degeneration, and Cataract in Thailand: A Multicenter Survey Using Time Trade-Off, EQ-5D-5L, and Health Utility Index 3.Value Health Reg Issues. 2024 Nov;44:101030. doi: 10.1016/j.vhri.2024.101030. Epub 2024 Jul 31. Value Health Reg Issues. 2024. PMID: 39089062
-
Comparing the discriminative validity of two generic and one disease-specific health-related quality of life measures in a sample of patients with dry eye.Value Health. 2005 Mar-Apr;8(2):168-74. doi: 10.1111/j.1524-4733.2005.03074.x. Value Health. 2005. PMID: 15804325
-
EQ-5D-5L health utility scores in Australian adults with inherited retinal diseases: A cross-sectional survey.Acta Ophthalmol. 2024 Aug;102(5):e736-e745. doi: 10.1111/aos.16634. Epub 2024 Jan 16. Acta Ophthalmol. 2024. PMID: 38226448
-
Comparison of EQ-5D-5L, VAS, and SF-6D in Thai Patients on Peritoneal Dialysis.Value Health Reg Issues. 2019 May;18:59-64. doi: 10.1016/j.vhri.2018.08.005. Epub 2018 Nov 28. Value Health Reg Issues. 2019. PMID: 30502661
Cited by
-
An Updated Economic Evaluation of HLA-B*58:01 Genotype Testing in Gouty Patients for Preventing Severe Allopurinol Hypersensitivity in Thailand.ACR Open Rheumatol. 2025 Aug;7(8):e70093. doi: 10.1002/acr2.70093. ACR Open Rheumatol. 2025. PMID: 40829930 Free PMC article.
References
-
- Stapleton F, Alves M, Bunya VY, Jalbert I, Lekhanont K, Malet F, Na KS, Schaumberg D, Uchino M, Vehof J, et al. TFOS DEWS II Epidemiology Report. Ocul Surf. 2017;15(3):334–65. - PubMed
-
- Sullivan DA, Rocha EM, Aragona P, Clayton JA, Ding J, Golebiowski B, Hampel U, McDermott AM, Schaumberg DA, Srinivasan S, et al. TFOS DEWS II sex, gender, and hormones Report. Ocul Surf. 2017;15(3):284–333. - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources